New mRNA vaccine is more effective and less costly to develop. A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a ...
Moderna’s efforts to advance its cancer pipeline “make sense” against the backdrop of a more skeptical U.S. government attitude toward infectious disease vaccines, the company’s oncology chief told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback